Health News Archive - February 18, 2009
WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- The winners of the MetLife Foundation Awards for Medical Research in Alzheimer's Disease will be announced in Washington, D.C.
WHAT: The National Academy of Sciences will release a report on the scientific shortcomings and policy changes that could improve the forensic sciences. The report, "Strengthening Forensic Science in the United States: A Path Forward," reviews the state of the forensic techniques--fingerprinting, firearms identification and analysis of bite marks, blood spatter, hair and handwriting--used in court proceedings. AVAILABLE FOR INTERVIEW: We have an internationally regarded trace evidence expert who can comment on the conclusions and recommendations regarding trace evidence and forensic hair analysis. Richard E.
Nearly 150,000 PCIs Were Performed on AMI Patients in 2008, According to Millennium Research Group WALTHAM, Mass., Feb.
WALTHAM, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc.
GREAT RIVER, N.Y., Feb. 18 /PRNewswire/ -- Tesia-PCI has successfully implemented and launched Real Time Claims processing capabilities with United Concordia Companies, Inc., a national dental insurer headquartered in Harrisburg, PA.
Reviewer Finder to Speed up the Peer Review Process! COLUMBIA, S.C., Feb. 18 /PRNewswire-FirstCall/ -- Collexis Holdings Inc.
FORT LAUDERDALE, Fla., Feb. 18 /PRNewswire-FirstCall/ -- Natural Harmony Foods, Inc., (Pink Sheets: NHYF) is pleased to announce that the Company was notified that it has succeeded in moving on to the next round of judging in Health magazine's America's Healthiest Food Awards.
Results of first clinical trial indicate pre-converted form of Coenzyme Q10 positively impacted heart function in critically ill subjects HOUSTON, Feb.
LA JOLLA, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has submitted to the U.S. Food and Drug Administration (FDA) an amended Phase 3 protocol for ATPace to be reviewed as a Special Protocol Assessment (SPA).
VIDAZA Restores Gene Function to Double Survival and Increase Transfusion Independence CROSSWICKS, N.J., Feb.